136
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Effect of piracetam and vitamin E on phosphamidon-induced impairment of memory and oxidative stress in rats

, , , , , & show all
Pages 48-54 | Received 24 Jun 2011, Accepted 20 Sep 2011, Published online: 11 Feb 2012

References

  • Ahmed, T., Pathak, R., Mustafa, M. D., Kar, R., Tripathi, A. K., Ahmed, R. S., et al. (2011). Ameliorating effect of N-acetylcysteine and curcumin on pesticide-induced oxidative DNA damage in human peripheral blood mononuclear cells. Environ Monit Assess 179:293–299.
  • Banerjee, B. D., Seth, V., Bhattacharya, A., Pasha, S. T., Chakraborthy, A. K. (1999). Biochemical effects of some pesticides on lipid peroxidation and free radical scavengers. Toxicol Lett 107:33–47.
  • Buresova, O., Bures, J. (1976). Piracetam induced facilitation of interhemispheric transfer of visual information in rats. Psychopharmacologia 46:93–102.
  • Calviello, G., Piccioni, E., Boninsegna, A., Tedesco, B., Maggiano, N., Serini, S., et al. (2006). DNA damage and apoptosis induction by the pesticide mancozeb in rat cells: involvement of the oxidative mechanism. Toxicol Appl Pharmacol 211:87–96.
  • Chuang, C. C., Lin, T. S., Tsai, M. C. (2002). Delayed neuropathy and myelopathy after organophosphate intoxication. N Engl J Med 347:1119–1121.
  • Croisile, B., Trillet, M., Fondarai, J., Laurent, B., Mauguiere, F., Billardon, M. (1993). Long-term and high-dose piracetam treatment of Alzheimer’s disease. Neurology 43:301–305.
  • Dhingra, D., Parle, M., Kulkarni, S. K. (2003). Effect of combination of insulin with dextrose, D(-) fructose and diet on learning and memory in mice. Indian J Pharmacol 35:151–156.
  • Dimond, S. J., Scammell, R. E., Pryce, I. G., Huws, D., Gray, C. (1979). Some effects of piracetam on chronic schizophrenia. Psychopharmacologia 64:341–348.
  • Ellman, G. L. (1959). Tissue sulphydryl groups. Arch Biochem Biophy 82:70–77.
  • Giurgea, C. E. (1982). The nootropic concept and its prospective implications. Drug Dev Res 2:441–446.
  • Grossman, L., Stewart, A., Gaikwad, S., Utterback, E., Wu, N., Dileo, J., et al. (2011). Effects of piracetam on behavior and memory in adult zebrafish. Brain Res Bull 85:58–63.
  • Grundman, M. (2000). Vitamin E and Alzheimer’s disease: the basis for additional clinical trials. Am J Clin Nutr 71:630S– 636S.
  • Gupta, S., Garg, G. R., Bharal, N., Mediratta, P. K., Banerjee, B. D., Sharma, K. K. (2009). Reversal of propoxur-induced impairment of step-down passive avoidance, transfer latency, and oxidative stress by piracetam and ascorbic acid in rats. Environ Toxicol Pharmacol 28:403–408.
  • Hakkrainen, H., Hakamies, L. (1928). Piracetam in the treatment of post-concussional syndrome. Eur Neurol 17:50–55.
  • Hayes, W. J., Laws, E. R. (Eds.). (1991). Handbook of pesticide toxicology. New York: Academic.
  • Ichitani, Y., Okaichi, H., Yoshikawa, T., Ibata, Y. (1992). Learning behaviour in chronic vitamin E–deficient and −supplemented rats: radial arm maze learning and passive avoidance response. Behav Brain Res 51:157–164.
  • Itoh, J., Nabeshima, T., Kameyama, T. (1990). Utility of an elevated plus-maze for the evaluation of memory in mice: effect of nootropics, scopolamine, and electroconvulsive shock. Psychopharmacology 101:27–33.
  • Jokanović, M., Maksimović, M., Stepanović, R. M. (1995). Interaction of phosphamidon with neuropathy target esterase and acetylcholinesterase of hen brain. Arch Toxicol 69:425–428.
  • Joshi, H., Parle, M. (2006). Brahmi rasayana improves learning and memory in mice. Evid Based Complement Alternat Med 3:79–85.
  • Joshi, V., Arora, T., Mehta, A. K., Sharma, A. K., Rathor, N., Mehta, K. D., et al. (2010). Effect of phosphamidon on convulsive behavior and biochemical parameters: modulation by progesterone and 4′-chlorodiazepam in rats. Naunyn Schmiedebergs Arch Pharmacol 382:311–320.
  • Keil, U., Scherping, I., Hauptmann, S., Schuessel, K., Eckert, A., Muller, W. E. (2006). Piracetam improves mitochondrial dysfunction following oxidative stress. Br J Pharmacol 147:199–208.
  • Kovalev, G. I., Firstova, I., Salimov, R. M. (2008). Effects of piracetam and meclofenoxate on the brain NMDA and nicotinic receptors in mice with different exploratory efficacy in the cross maze test. Eksp Klin Farmakol 71:12–17.
  • Mehta, K. D., Garg, G. R., Mehta, A. K., Arora, T., Sharma, A. K., Khanna, N., et al. (2010). Reversal of propoxur-induced impairment of memory and oxidative stress by 4′-chlorodiazepam in rats. Naunyn Schmiedebergs Arch Pharmacol 381:1–10.
  • Meydani, M. (1995). Vitamin E. Lancet 345:170–175.
  • Mondadori, C., Hengerer, B., Ducret, T., Borkowoski, J. (1994). Delayed emergence of effects of memory-enhancing drugs: implications for the dynamics of long-term memory. Proc Natl Acad Sci U S A 91:2041–2045.
  • Müller, W. E., Eckert, G. P., Eckert, A. (1999). Piracetam: novelty in a unique mode of action. Pharmacopsychiatry 32:2–9.
  • Naidu, P. S., Singh, A., Kulkarni, K. S. (2004). Quercitin and reserpine induced orofacial dyskinesia. Pharmacology 70:59–67.
  • Naqvi, S. M., Hasan, M. (1990). Dose-related accumulation of organophosphate phosphamidon in discrete regions of the CNS: correlation with its neurotoxicity. Pharmacol Toxicol 67:47–48.
  • Naqvi, S. M., Hasan, M. (1991). Phosphamidon neurotoxicity: protection by acetylhomocysteine thiolactone. Neuroreport 2:61–63.
  • Naqvi, S. M., Hasan, M. (1992). Acetylhomocysteine thiolactone protection against phosphamidon-induced alteration of regional superoxide dismutase activity in the central nervous system and its correlation with altered lipid peroxidation. Indian J Exp Biol 30:850–852.
  • Nickolson, V., Wolthuis, O. (1976). Effect of the acquisition—enhancing drug piracetam on rat cerebral energy metabolism. Biochem Pharmacol 25:2241–2244.
  • Ohkawa, H., Ohishi, N., Yagi, K. (1979). Assay of lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 95:351–358.
  • Okuyama, S., Aihara, H. (1988). Actions of nootropic drugs on transcallosal response of rats. Neuropharmacology 27:67–72.
  • Pena-Llopis, S., Ferrando, M. D., Pena, J. B. (2003). Increased recovery of brain acetylcholinesterase activity in dichlorvos-intoxicated European eels Anguilla anguilla by bath treatment with N-acetylcysteine. Dis Aquat Organ 55:237–245.
  • Reddy, M. S., Rao, K. V. (1991). Phosphamidon, methylparathion, and dichlorvos impact on tissue oxidative metabolism in penaeid prawn, Metapenaeus monoceros. Biochem Int 23:439–447.
  • Sahaya, K., Mahajan, P., Mediratta, P. K., Ahmed, R. S., Sharma, K. K. (2007). Reversal of lindane-induced impairment of step-down passive avoidance and oxidative stress by neurosteroids in rats. Toxicology 239:116–126.
  • Seth, V., Banerjee, B. D., Bhattacharya, A., Pasha, S. T., Chakravorty, A. K. (2001). Pesticide induced alterations in acetylcholine esterase and gamma glutamyl transpeptidase activities and glutathione level in lymphocytes of human poisoning cases. Clin Biochem 34:427–429.
  • Sharma, A. K., Bhattacharya, S. K., Khanna, N., Tripathi, A. K., Arora, T., Mehta, A.K., et al. (2011a). Effect of progesterone on phosphamidon-induced impairment of memory and oxidative stress in rats. Hum Exp Toxicol 30:1626–1634.
  • Sharma, A. K., Mehta, A. K., Rathor, N., Chalawadi Hanumantappa, M. K., Khanna, N., Bhattacharya, S. K. (2011b). Melatonin attenuates cognitive dysfunction and reduces neural oxidative stress induced by phosphamidon. Fundam Clin Pharmacol Jul 26. doi: 10.1111/j.1472–8206.2011.00977.x. [Epub ahead of print]
  • Socci, D. J., Crandall, B. M., Arendash, G. W. (1995). Chronic antioxidant treatment improves the cognitive performance of aged rats. Brain Res 693:88–94.
  • Suke, S. G., Ahmed, R. S., Pathak, R., Tripathi, A. K., Banerjee, B. D. (2008). Attenuation of phosphamidon-induced oxidative stress and immune dysfunction in rats treated with N-acetylcysteine. Braz J Med Biol Res 41:765–768.
  • Suke, S. G., Ahmed, R. S., Tripathi, A. K., Chakraborti, A., Banerjee, B. D. (2006). Immunotoxicity of phosphamidon following subchronic exposure in albino rats. Indian J Exp Biol 44:316–320.
  • Tacconi, M., Wurtman, R. (1986). Piracetam: physiological disposition and mechanism of action. In: Fahn, S., Marsden, C. D., Van Woert, M. H. (Eds.), Advances in neurology: myoclonus (vol. 43). New York: Raven.
  • Waegemans, T., Wilsher, C. R., Danniau, A., Ferris, S. H., Kurz, A., Winblad, B. (2002). Clinical efficacy of piracetam in cognitive impairment: a meta-analysis. Dement Geriatr Cogn Disord 13:217–224.
  • Winblad, B. (2005). Piracetam: a review of pharmacological properties and clinical uses. CNS Drug Rev 11:169–182.
  • Zimmer, S., Stocker, A., Sarbolouki, M. N., Spycher, S. E., Sassoon, J., Azzi, A. A. (2000). Novel human tocopherol associated protein: cloning, in vitro expression, and characterization. J Biol Chem 275:672–680.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.